A Phase II Study to Evaluate the Efficacy and Safety of MT921 in Subjects With Moderate to Severe Submental Fat
Clinical trial NCT04144049 · COMPLETED
Trial details
- NCT number
- NCT04144049
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2020-03-10
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.